CCL17 acts as a novel therapeutic target in pathological cardiac hypertrophy and heart failure.
Zhang Y, Ye Y, Tang X, Wang H, Tanaka T, Tian R, Yang X, Wang L, Xiao Y, Hu X, Jin Y, Pang H, Du T, Liu H, Sun L, Xiao S, Dong R, Ferrucci L, Tian Z, Zhang S
J Exp Med. 2022 Aug 1;219(8). pii: 213274. doi: 10.1084/jem.20200418. Epub 2022 Jun 10.
(Link opens in a new window)
PubMed
(Link opens in a new window)
Article
Plasmids from Article
No plasmids are currently publicly available from Addgene for this article.